You are my personal exam tutor for Pathology Anatomy. All study materials have been provided to you - PPTs, notes, course handout, reference book guide, and previous year papers including the most recent paper available. Use can use any other source if you want to add more information you can. About the exam: The professor has {25} years of experience in this field. Based on the papers provided, the exam pattern is {conceptual / theory based / mixed} no straight definitions or derivations unless mentioned in the papers. He expects core concepts to be deeply understood and applied. What I need: Go through the course handout unit by unit. For every unit, cover every topic and term mentioned. For each topic explain: The core concept in simple language Why it matters and how it connects to other topics How this professor specifically expects it to be answered based on his paper pattern A relevant example or diagram where needed Any numerical approach if that topic has numerical applications Format it unit wise, topic wise, in a structured way I can study sequentially. Goal: I should be able to score (100%} after studying this. Teach me accordingly

Reading File

Running Command

Finding Sources

I now have everything I need. Let me compile the comprehensive study guide based on the complete PPT content.

📚 PATHOLOGICAL ANATOMY — TUMOURS: Complete Exam Study Guide

Based on your PPT (111 slides), Robbins Pathology, and the professor's exam pattern. Study this sequentially — every topic, every term, every concept from your slides.

HOW TO USE THIS GUIDE

Your professor is conceptual + applied — he will NOT ask "define fibroma." He will ask "How does fibroma differ from fibrosarcoma microscopically and clinically?" or "A young woman has a firm abdominal wall mass during pregnancy — what is it, why, and what type of growth does it show?" This guide is built around that style.

UNIT 1: FUNDAMENTALS OF TUMOUR BIOLOGY

Topic 1.1 — What is a Tumour?

Core Concept (Slide 2):

A tumour is a pathologic process characterized by uncontrollable, impetuous, inadequate-to-the-organism's-requirements reproduction of non-differentiated cells.

Break this down — every word matters for the exam:

Uncontrollable → the cell escapes normal growth regulation (no response to stop signals)
Impetuous → rapid, forceful, autonomous
Inadequate to requirements → the organism doesn't "need" these cells; they serve no physiologic purpose
Non-differentiated → cells have lost their mature tissue identity

Why it matters: This definition distinguishes a tumour from normal repair/regeneration (which is controlled, purposeful, and produces differentiated cells). Connect this to hyperplasia, which IS controlled and IS adequate — so hyperplasia alone is NOT a tumour.

How the professor tests this: He will likely give you a scenario and ask you to apply the definition — e.g., "A tissue grows after injury but stops when healing is complete — is this a tumour?" (Answer: No — it is controlled and adequate.)

Topic 1.2 — How Tumours Differ from Normal Tissue (6 Parameters)

(Slide 3) Your professor explicitly listed 6 parameters. Know ALL 6 with examples:

Parameter	What changes in tumour
1. Metabolic processes	Aerobic glycolysis (Warburg effect) even with O₂; increased protein catabolism → cachexia
2. Structural (morphological) features	Tissue + cellular atypism (abnormal arrangement, cell shape, nuclear changes)
3. Antigenic structure	Tumour-specific antigens (TSA) and tumour-associated antigens (TAA) appear; normal antigens disappear
4. Ability to differentiate	Reduced or absent — cells are immature, cannot perform the original tissue's function
5. Peculiarities of growth	Autonomous, infiltrating, expansive, unicentric/multicentric
6. Functional features	May secrete abnormal hormones (paraneoplastic syndromes), produce abnormal proteins

Exam tip: The professor may ask: "Which parameter of tumour tissue difference from normal tissue underlies cachexia?" → Answer: Metabolic processes (abnormal protein and carbohydrate metabolism).

Topic 1.3 — Morphogenetic Variants of Tumour Origin

(Slide 4) Tumour growth can begin in two ways:

From previous precancerous processes — tumour arises from pre-existing lesions (metaplasia, dysplasia, chronic inflammation)
"De novo" / "off the bat" — tumour arises in apparently normal tissue without preceding changes

Connection: This directly links to Topic 1.4 (precancerous changes). The concept is: not every cancer is preceded by visible precancer — "de novo" origins remind you cancer can appear without warning signs.

Topic 1.4 — Precancerous Changes in Cells and Tissues

(Slide 5) Three types — know definitions and hierarchy:

1. Hyperplasia

Definition: Increase in cell NUMBER (not size) due to increased mitotic activity
Reversible? Yes — if stimulus removed
Is it atypical? In simple hyperplasia, NO. In atypical hyperplasia, YES
Example: Endometrial hyperplasia from excess estrogen

2. Metaplasia

Definition: Replacement of one mature cell type by another mature cell type (of a different kind) in response to chronic injury
Reversible? Yes, if stimulus removed early
Classic example: Barrett's esophagus — columnar epithelium replaces squamous; bronchial squamous metaplasia in smokers
Danger: Metaplasia → dysplasia → carcinoma (this is the progression pathway)

3. Dysplasia

Definition: Disordered growth — cells show increased mitoses, nuclear atypia, loss of polarity, but do NOT invade the basement membrane
Can affect: Epithelium, blood cells/lymphoid tissue, melanin-forming tissue (melanocytes)
Reversible? Mild/moderate may regress; severe dysplasia = carcinoma in situ risk
Key distinction: Dysplasia ≠ cancer (no invasion); if it invades = carcinoma

Exam application:

A Pap smear shows cells with enlarged nuclei, nuclear hyperchromia, loss of polarity, and increased N:C ratio. The basement membrane is intact. What is this? → Dysplasia (cervical intraepithelial neoplasia / CIN)

Topic 1.5 — Fuld's Theory of Tumour Progression

(Slide 6)

"A tumour is characterized by a continuous change in signs in the direction of increasing its malignancy."

Core concept: Tumours are not static — they evolve over time, acquiring more aggressive features through genetic instability:

Lose differentiation → become more anaplastic
Acquire ability to invade → then metastasize
Develop resistance to therapy

Why it matters: This explains WHY a benign tumour can become malignant over time, why metastases may be more aggressive than the primary, and why a tumour that responded to treatment may recur in a more resistant form.

Exam application: "A patient had a well-differentiated tumour 2 years ago. Now the same tumour shows poor differentiation and distant metastases. Which theory explains this?" → Fuld's tumour progression theory.

Topic 1.6 — Tumour Atypism

(Slide 7) Definition:

Tumour atypism is the set of properties that distinguish a tumour from normal tissue.

This is the MASTER concept — atypism has two types:

TUMOUR ATYPISM
├── MORPHOLOGICAL ATYPISM (Slide 8)
│   ├── Tissue atypism (Slide 9)
│   └── Cellular atypism (Slides 10-11)

1.6a — Tissue Atypism (Slide 9)

Violation of the anatomical and histological structure of the tumour compared to normal tissue.

3 Manifestations:

Incorrect ratio of tumour components (e.g., too much stroma vs. cells, or vice versa)
Chaotic arrangement of components (glands pointing in all directions, fibers disorganized)
Variety of forms and sizes of structural units (glands of varying shapes)

Present in: BOTH benign and malignant tumours Key fact: A benign tumour has only tissue atypism — no cellular atypism.

1.6b — Cellular Atypism (Slides 10-11)

Change in structure of tumour cells compared to normal cells.

7 Manifestations — memorize all:

Variation in cell SIZE (anisocytosis)
Variation in cell SHAPE (poikilocytosis)
Hyperchromia of nuclei (dark staining — more DNA, dense chromatin)
Increased size and number of nucleoli
Changes in nuclear-cytoplasmic ratio (nucleus becomes proportionally larger)
Violation of mitotic activity — more mitoses, PATHOLOGICAL mitoses (tripolar, asymmetric, multipolar)
Changes in ultrastructures (abnormal organelles at EM level)

Present in: Malignant tumours only Exam application: "What feature of cellular atypism can be used to distinguish benign from malignant tumours on microscopy?" → Pathological mitoses + hyperchromic nuclei + altered N:C ratio

Topic 1.7 — Organoid vs. Histioid Tumours (Slide 12)

Feature	Organoid Tumour	Histioid Tumour
Components	Distinct parenchyma + stroma	Predominantly cells; stroma poorly developed
Separation	Clear distinction between stroma and parenchyma	No clear separation
Examples	Most carcinomas	Some sarcomas, vascular tumours

Why it matters: Organoid tumours are more differentiated (structured like an organ). Histioid tumours lack that structure — more primitive, often more aggressive.

Topic 1.8 — Types of Tumour Growth

By Relation to Surrounding Tissues (Slide 13):

Type	Description	Clinical Significance
Expansive	Tumour PUSHES away surrounding tissue; forms a capsule/pseudocapsule	Benign tumour behavior; easily resectable
Infiltrating (Invasive/Destructive)	Tumour GROWS INTO and DESTROYS surrounding tissue	Malignant behavior; no capsule; difficult to resect completely
Appositional	Surrounding normal tissue undergoes neoplastic transformation	Rare; spread by transformation, not mechanical push

By Relation to Hollow Organ Lumen (Slide 14):

Type	Direction	Example
Exophytic	Into the CAVITY (inward into lumen)	Polypoid colon cancer, bladder papilloma
Endophytic	Into the WALL	Linitis plastica (stomach scirrhous cancer)

By Number of Initial Foci (Slide 15):

Type	Meaning
Unicentric	Single origin point
Multicentric	Multiple simultaneous foci (e.g., field cancerization in oral cavity, Paget's disease)

Topic 1.9 — Metastasis

(Slides 16-17)

Definition: Development of secondary (daughter) tumour nodes in organs/tissues DISTANT from the primary.

The 3-Step Process (Slide 16):

Separation of tumour cells from the primary node
Transfer through various pathways (blood, lymph, etc.)
Development of secondary tumour nodes (metastases)

4 Routes of Metastasis (Slide 17):

Lymphogenic — via lymphatic vessels → regional lymph nodes first (most common for carcinomas)
Haematogenous — via blood vessels (most common for sarcomas — to lungs and liver)
Perineural — along nerve sheaths (classic: pancreatic cancer, prostate cancer)
Implantation — direct spread across body cavities (peritoneal, pleural) → e.g., Krukenberg tumour

Sarcoma-specific rule (Slide 34): Sarcomas metastasize haematogenously. First metastases:

Lungs (for most sarcomas)
Liver (when primary is in unpaired abdominal organs)

Exam application: "A patient with retroperitoneal leiomyosarcoma — where would you expect the first metastases?" → Liver (unpaired abdominal organ → portal circulation → liver).

Topic 1.10 — Tumour Recurrence (Slide 18)

Recurrence = resumption of tumour growth at the site of its removal.

Mechanism: Incomplete surgical excision, residual tumour cells at margins.

Who recurs? Primarily malignant tumours — because:

Infiltrating growth leaves microscopic residual cells beyond the visible margin
Benign tumours with expansive growth can be completely excised → do NOT recur

Exception: Locally destructive tumours (desmoid, basal cell carcinoma) CAN recur even though they are "mature" because of their infiltrating growth.

Topic 1.11 — Effect of Tumour on the Body (Slide 19)

Local Effects:

Compression of surrounding tissues (vessels, nerves, ducts)
Destruction of surrounding tissues (malignant)

General (Systemic) Effects:

Metabolic disorders — carbohydrate, protein, vitamin metabolism disrupted
Cachexia — progressive wasting (due to TNF-α/cachectin, IL-6, proteolysis-inducing factor)
Anemia — blood loss from tumour ulceration + suppression of erythropoiesis
Coagulation disorders — DIC risk (especially acute promyelocytic leukemia, mucin-secreting adenocarcinomas)
Paraneoplastic syndromes — remote effects NOT due to direct invasion/metastasis:
- Ectopic hormone production (SCLC → ADH, ACTH)
- Hypercalcemia (PTHrP from squamous cell lung cancer)
- Clubbing, Eaton-Lambert syndrome

UNIT 2: TUMOUR CLASSIFICATION

Topic 2.1 — Two Major Classification Systems (Slide 20)

Classification	Basis	Use
Clinical-Morphological	Behaviour (benign vs. malignant vs. locally destructive)	Clinical management
Histogenetic (WHO International)	Cell/tissue of origin	Pathological diagnosis, universal naming

Topic 2.2 — Histogenetic (WHO) Classification — 7 Groups (Slide 21)

Memorize all 7:

Epithelial tumours without specific localization (organ non-specific)
Tumours of exo/endocrine glands and epithelial integuments (organ-specific)
Mesenchymal tumours
Tumours of melanin-forming tissue
Tumours of nervous system and meninges
Tumours of the blood system (hematologic malignancies)
Teratomas (germ cell / pluripotent cell origin)

Topic 2.3 — Classification by Degree of Maturity (Slide 22)

Type	Composition	Corresponds to
Mature	Mature, differentiated cells	Benign tumour
Immature	Poorly or undifferentiated cells	Malignant tumour

Topic 2.4 — Clinical-Morphological Classification (Slides 23-27)

Three categories:

1. Benign Tumours (Slide 24) — 7 characteristics:

Consist of differentiated cells (mature)
Have tissue atypism only
Expansive growth
Slower pace of growth
Do NOT metastasize
Do NOT recur
Local effect only (compression)

2. Malignant Tumours (Slide 25) — 8 characteristics:

Consist of poorly or undifferentiated cells (immature)
Have tissue atypism
Have cellular atypism
Infiltrating growth
Fast growth rate
Metastasize
Recur
Local + general effects (destruction + cachexia, etc.)

3. Tumours with Locally Destructive Growth (Slide 26-27):

Usually mature tumours with ONLY ONE malignant property: infiltrating (destructive) growth

They do NOT metastasize, do NOT recur, but DO invade locally.

Examples (Slide 27) — know all 5:

Juvenile angiofibroma of the nasopharynx (young males 8-18)
Desmoid (young women, anterior abdominal wall)
Capillary hypertrophic haemangioma
Papillary (proliferating) cystadenoma of the ovary
Basal cell carcinoma (skin — locally invasive, almost never metastasizes)

Topic 2.5 — Borderline Tumours (Slides 28-29)

A tumour whose behaviour cannot be predicted by its morphological structure — may behave benignly in some cases, malignantly in others.

Examples (Slide 29):

Papillary (proliferating) cystadenoma of the ovary (appears in both locally destructive AND borderline lists!)
Granulosa tumour of the ovary
Adenoma of the nasal septum

Exam application: "Why is a granulosa tumour of the ovary classified as a borderline tumour?" → Because morphology alone cannot predict whether it will behave as benign or malignant — it requires long-term clinical follow-up.

Topic 2.6 — Prognostic Parameters for Malignant Tumours (Slide 30)

3 key parameters:

Stage of the tumour process — depth of invasion (T), lymph node involvement (N), distant metastases (M) → TNM staging
Morphological degree of malignancy — grade of differentiation (G1 well → G3/G4 anaplastic)
Size of the tumour node — relevant for specific tumours (e.g., breast: ≤2 cm = T1; >5 cm = T3)

UNIT 3: MESENCHYMAL TUMOURS

Topic 3.1 — What is Mesenchyme? (Slide 32)

Mesenchyme is the germ (embryonic) tissue that is the source for development of connective, fat, muscle, and other tissues.

Critical fact: In the body of an adult, mesenchyme is ABSENT. What remains are the mature tissues that derived from it.

Why this matters: Mesenchymal tumours are named after the MATURE adult tissue they resemble, not after embryonic mesenchyme. "Mesenchymal" just identifies their lineage.

Topic 3.2 — Source Tissues for Mesenchymal Tumours (Slide 33)

8 source tissues — memorize:

Connective (fibrous) tissue
Fatty tissue
Muscle tissue (smooth + skeletal)
Cartilage tissue
Bone tissue
Blood and lymphatic vessels
Serous membranes
Synovial membranes

Topic 3.3 — The Complete Mesenchymal Tumour Table (Slide 36)

This is the single most testable table in your slides. Know EVERY pair:

Source Tissue	Mature (Benign)	Immature (Malignant)
Connective tissue	Fibroma	Fibrosarcoma
(Special)	Desmoid	—
(Special)	Juvenile nasopharyngeal angiofibroma	—
Fatty tissue	Lipoma	Liposarcoma
Cartilage	Chondroma	Chondrosarcoma
Bones	Osteoma	Osteosarcoma
Blood vessels	Haemangioma	Angiosarcoma
Lymphatic vessels	Lymphangioma	Lymphangiosarcoma
Skeletal muscle	Rhabdomyoma	Rhabdomyosarcoma
Smooth muscle	Leiomyoma	Leiomyosarcoma
Serous membranes	Benign mesothelioma (rare)	Malignant mesothelioma
Synovial membranes	Benign synovioma	Malignant synovioma

Topic 3.4 — Naming Logic (Slide 37-38)

Rule for any mesenchymal tumour definition:

State whether it is (1) benign (mature) or malignant (immature) + (2) genesis (from which tissue)

Sarcoma definition (Slide 38):

Sarcoma = malignant tumour of mesenchymal genesis tissue (from Greek "sarcos" = meat/flesh — the cut surface looks like raw fish/meat)

Topic 3.5 — Connective Tissue Tumours (Slides 39-51)

FIBROMA (Slides 40-42)

Type: Mature, benign
Composition: Bundles of collagen fibres and fibrocytes
Variants: Dense fibroma (more fibres, fewer cells); Soft fibroma (more cells, fewer fibres)
Growth: Expansive
Appearance: Firm, white-grey, encapsulated nodule

DESMOID (Fibromatosis Desmoid) (Slides 43-45)

Type: Connective tissue tumour with locally destructive growth (NOT benign, NOT malignant)
Structure: Built like a dense fibroma but infiltrates locally
Classic patient: Young women, during or after pregnancy, on the anterior abdominal wall
Why? Hormonal influence (estrogen stimulates fibroblast proliferation); abdominal wall trauma during pregnancy
Behaviour: Does NOT metastasize; DOES locally infiltrate → high recurrence after surgery

Exam scenario: "A 28-year-old woman, 3 months postpartum, presents with a firm mass in the anterior abdominal wall. Histology shows dense fibrous tissue with spindle cells, no cellular atypia, but infiltrative margins. What is the diagnosis and classification?" → Desmoid (fibromatosis desmoid) — tumour with locally destructive growth.

JUVENILE ANGIOFIBROMA OF THE NASOPHARYNX (Slides 46-48)

Type: Locally destructive growth
Structure: Built like fibroma, rich in blood vessels, localized in nasopharynx
Classic patient: Young males 8-18 years (most often 13-16)
Prognosis: Unfavorable — despite being "mature," it infiltrates the skull base, erodes bone
Key point: Bleeds profusely — vascularity is a defining feature

FIBROSARCOMA (Slides 49-51)

Type: Malignant (immature) connective tissue tumour
Micro: Herringbone/fishbone pattern of malignant spindle cells; cellular atypism, pathological mitoses
Comparison with fibroma: Fibroma = orderly bundles, no cellular atypia; Fibrosarcoma = disordered, atypical, mitoses

Topic 3.6 — Fatty Tissue Tumours (Slides 52-57)

LIPOMA (Slides 52-54)

Mature benign tumour of fatty tissue
Macro: Soft, yellowish, lobulated, encapsulated
Micro: Mature adipocytes with no atypia, thin fibrous septa

LIPOSARCOMA (Slides 55-56)

Malignant fatty tumour
Micro: Lipoblasts (vacuolated cells pushing nucleus to periphery = "signet ring-like" but with fat) — the hallmark cell
Various grades: Well-differentiated (myxoid) to pleomorphic
Distinguished from lipoma by: cellular atypia, lipoblasts, infiltration

Comparison slide (57): Lipoma = uniform mature fat cells. Liposarcoma = atypical cells, lipoblasts, irregular.

Topic 3.7 — Cartilage Tumours (Slides 58-63)

CHONDROMA (Slides 58-60)

Mature benign tumour of cartilage
Micro: Mature chondrocytes in lacunae, hyaline matrix, lobular architecture
Types: Enchondroma (inside bone), Ecchondroma (on bone surface)

CHONDROSARCOMA (Slides 61-62)

Malignant cartilage tumour
Micro: Atypical chondrocytes (binucleated cells, hyperchromatism), irregular lobules, myxoid changes
Prognosis: Relatively favorable (Slide 81) — slow-growing, low-grade chondrosarcoma responds poorly to chemo but has better surgical outcomes

Topic 3.8 — Vascular Tumours (Slides 64-72)

HAEMANGIOMA (Slide 64) — 4 types:

Capillary haemangioma (Slides 65-68) — small capillary-sized vessels, compact lobules; can be hypertrophic (locally destructive)
Venous haemangioma — large, thin-walled venous channels
Cavernous haemangioma (Slides 69-70) — large blood-filled caverns with thin walls; common in liver
Haemangiopericytoma — tumour of pericytes (cells surrounding capillaries); can be malignant

HAEMANGIOSARCOMA / ANGIOSARCOMA (Slides 71-72)

Malignant vascular tumour
High-grade malignancy (Slide 80) — among the worst prognosis sarcomas
Associated with: vinyl chloride (hepatic angiosarcoma), post-radiation, chronic lymphedema (Stewart-Treves syndrome)

Topic 3.9 — Muscle Tumours (Slides 73-79)

LEIOMYOMA (Slides 73-75)

Mature benign smooth muscle tumour
Most common in: Uterus (fibroids/myomas)
Micro: Interlacing bundles of spindle-shaped smooth muscle cells with cigar-shaped nuclei

FIBROMYOMA (Slide 76, Van Gieson stain)

Leiomyoma with prominent fibrous (connective tissue) component
Van Gieson stain: collagen = red, muscle = yellow

RHABDOMYOMA (Slide 77)

Mature benign skeletal muscle tumour (very rare)

LEIOMYOSARCOMA (Slide 78)

Malignant smooth muscle tumour
Micro: Smooth muscle cells with cellular atypism, pathological mitoses

RHABDOMYOSARCOMA (Slide 79)

Malignant skeletal muscle tumour
Most common soft tissue sarcoma in children
Micro: Rhabdomyoblasts (large eosinophilic cells, cross-striations)

Topic 3.10 — Sarcoma Prognosis (Slides 80-81)

High Malignancy (Poor Prognosis) — (Slide 80):

Osteosarcoma
Haemangiosarcoma (Angiosarcoma)
Malignant synovioma (synovial sarcoma)

Relatively Favorable Prognosis — (Slide 81):

Differentiated fibrosarcoma
Highly differentiated liposarcoma
Chondrosarcoma

Exam application: "Compare the prognosis of osteosarcoma vs. chondrosarcoma." → Osteosarcoma = high malignancy, poor prognosis, early haematogenous mets to lungs. → Chondrosarcoma = relatively favorable, slow growing.

UNIT 4: EPITHELIAL TUMOURS

Topic 4.1 — Carcinoma Definition (Slide 83)

Carcinoma = immature, malignant tumour that develops from epithelial cells.

Contrast with sarcoma: Sarcoma = mesenchymal origin. Carcinoma = epithelial origin.

Topic 4.2 — Two Main Types of Carcinoma (Slide 84)

Depends on the epithelium of origin:

Origin	Carcinoma Type
Squamous (transitional) epithelium	Squamous cell carcinoma
Glandular epithelium	Adenogenic carcinomas

Topic 4.3 — Squamous Epithelium Tumours

PAPILLOMA (Slides 86-88)

Mature tumour developing from multi-layered squamous (flat) or transitional epithelium

Benign — tissue atypism only
Macro: Cauliflower-like, finger-like projections (papillae) with fibrovascular core
Micro: Papillary projections covered by stratified squamous epithelium; well-differentiated, no atypia
Locations: Skin, oral mucosa, larynx, urinary bladder (transitional), cervix (HPV-related)
Epithelium shown (Slide 85): Normal squamous epithelium — basal → spinous → granular → cornified layers

SQUAMOUS CELL CARCINOMA (Slides 89-92)

Two types (Slide 89):

Squamous cell keratinizing carcinoma — tumour cells form keratin pearls (concentric laminated whorls of keratin = "cancer pearls")
Squamous cell non-keratinizing carcinoma — no keratin production; more undifferentiated; worse prognosis

Microscopy comparison (Slide 92):

Keratinizing: cancer pearl formation, polygonal cells with abundant eosinophilic cytoplasm, intercellular bridges
Non-keratinizing: no pearls, high N:C ratio, many mitoses, smaller cells

Exam application: "Which type of squamous cell carcinoma has a better prognosis?" → Keratinizing — more differentiated, slower growing.

Topic 4.4 — Glandular (Columnar) Epithelium Tumours

ADENOMA (Slides 94-101)

Mature tumour developing from glandular epithelium

6 Morphological variants (Slide 95):

Cystic adenoma (Slides 96-97) — cyst formation; glandular cavities dilate into cysts (cystadenoma)
Papillary adenoma (Slides 98-99) — papillary (finger-like) projections into the lumen
Fibroadenoma (Slides 100-101) — fibrous stroma + glandular elements (classic in breast)
Trabecular adenoma — cells arranged in trabeculae (bars/cords)
Tubular adenoma — tubular gland-like structures
Alveolar adenoma — alveolar (saclike) arrangement

Columnar epithelium shown (Slide 93): Normal glandular epithelium for orientation.

Topic 4.5 — Adenogenic Carcinomas (Slides 103-110)

Full classification (Slide 103):

ADENOGENIC CARCINOMAS
├── WELL-DIFFERENTIATED
│   └── Adenocarcinoma
└── POORLY-DIFFERENTIATED
    ├── Solid carcinoma
    ├── Medullary carcinoma
    ├── Fibrous (Scirrhous) carcinoma
    ├── Mucoid (Signet ring cell) carcinoma
    ├── Small cell carcinoma
    └── Large cell carcinoma

ADENOCARCINOMA (Slides 104-106)

Histological type of well-differentiated adenogenic cancer whose tumour cells form glandular structures

Micro: Back-to-back glands, columnar cells with nuclear atypia, no normal architecture
The best-differentiated adenogenic cancer

POORLY-DIFFERENTIATED CARCINOMAS (Slides 107-108):

Type	Key Microscopic Feature
Solid carcinoma	Tumour cells in strands, complexes, fields separated by stroma fibres
Fibrous/Scirrhous carcinoma (Skirr)	Small cell complexes embedded in massive coarse-fibrous stroma (desmoplastic reaction)
Medullary carcinoma	Parenchyma (cancer cells) DOMINATES the stroma
Mucoid (Signet ring cell) carcinoma	Cells produce large amounts of mucus → nucleus pushed to periphery → signet ring appearance

Stroma ratio rule — classic exam question:

Medullary: more parenchyma than stroma → soft, brain-like consistency
Scirrhous/Skirr: more stroma than parenchyma → rock-hard ("scirrhous" = hard)
Solid: roughly equal parenchyma and stroma in sheets/cords

Exam application: "A gastric cancer biopsy shows cells with cytoplasmic mucin pushing the nucleus to one side, giving a ring-like appearance. What type of carcinoma is this?" → Mucoid (signet ring cell) carcinoma — poorly differentiated adenogenic cancer.

Topic 4.6 — Cancers with Early Extensive Metastases (Slide 111)

3 organs — know all:

Breast cancer
Lung cancer
Prostate cancer

Why these three?

Breast → haematogenous spread (bone, lung, liver, brain) early
Lung → central location near vessels → early vascular invasion
Prostate → vertebral venous plexus (Batson's) → bone metastases

MASTER COMPARISON TABLES

Benign vs. Malignant — Complete Comparison

Feature	Benign	Malignant
Differentiation	Mature (differentiated)	Immature (poorly/undifferentiated)
Tissue atypism	YES	YES
Cellular atypism	NO	YES
Growth	Expansive	Infiltrating
Growth rate	Slow	Fast
Capsule	Usually present	Absent
Metastasis	NO	YES
Recurrence	NO	YES
Local effect	Compression	Destruction
General effect	Usually none	Cachexia, anemia, paraneoplastic

The 3 Special Growth Categories

Category	Growth	Metastasis	Recurrence	Example
Benign	Expansive	No	No	Lipoma
Locally destructive	Infiltrating	No	Yes	Desmoid, Basal cell carcinoma
Malignant	Infiltrating	Yes	Yes	Fibrosarcoma

Naming Convention for All Tumours

Origin	Benign	Malignant
Epithelium (squamous)	Papilloma	Squamous cell carcinoma
Epithelium (glandular)	Adenoma	Adenocarcinoma / Carcinoma
Connective tissue	Fibroma	Fibrosarcoma
Fat	Lipoma	Liposarcoma
Muscle (smooth)	Leiomyoma	Leiomyosarcoma
Muscle (skeletal)	Rhabdomyoma	Rhabdomyosarcoma
Cartilage	Chondroma	Chondrosarcoma
Bone	Osteoma	Osteosarcoma
Vessels	Haemangioma	Angiosarcoma
Synovium	Benign synovioma	Malignant synovioma

HIGH-YIELD EXAM SCENARIOS (Professor-Style Questions)

Q1: A 14-year-old boy presents with recurrent severe nosebleeds and a nasopharyngeal mass. Biopsy shows fibrous tissue rich in thin-walled vessels. Classify this tumour. → Juvenile angiofibroma of the nasopharynx — locally destructive tumour. Mature tissue but infiltrating growth. Prognosis unfavorable.

Q2: On histology, a tumour shows: (a) tissue atypism, (b) no cellular atypism, (c) expansive growth, (d) encapsulation. Is this benign or malignant? → Benign — all four features are characteristic of a mature (benign) tumour.

Q3: A tumour biopsy shows: hyperchromatic nuclei, increased N:C ratio, pathological tripolar mitoses, infiltrating margins. What type of atypism? What class? → Cellular atypism present → Malignant tumour (immature).

Q4: A patient had a well-differentiated squamous cell carcinoma 3 years ago. Now the recurrence shows no differentiation and distant metastases. What principle does this illustrate? → Fuld's theory of tumour progression — tumours continuously change toward increasing malignancy.

Q5: What distinguishes adenocarcinoma from solid carcinoma? → Adenocarcinoma = well-differentiated, forms glandular structures. Solid carcinoma = poorly differentiated, no glands, grows in strands/complexes/fields.

Q6: A mucin-secreting gastric cancer shows cells with peripheral nuclei shaped like a ring. What is it and what does it signify? → Signet ring cell (mucoid) carcinoma — poorly differentiated adenogenic cancer, poor prognosis, early peritoneal spread.

Q7: Why do sarcoma metastases appear in the lungs first rather than lymph nodes? → Sarcomas preferentially metastasize haematogenously (via blood). The lungs are the first capillary bed encountered by tumor emboli from systemic veins.

Q8: What 3 parameters determine the prognosis of a malignant tumour? → Stage (TNM — depth, nodes, distant mets) + Morphological grade (differentiation) + Tumour size (for specific tumours).

QUICK-FIRE MEMORY ANCHORS

Fuld = Progression (tumours get worse over time)
Sarcoma = Meat/Fish (Greek sarcos); Haematogenous mets → Lungs or Liver
Carcinoma = Epithelial origin (oma = benign → papilloma, adenoma)
Desmoid = Young woman + post-pregnancy + anterior abdominal wall + infiltrates but no mets
Angiofibroma = Young man 13-16 + nasopharynx + bleeds + infiltrates
Scirrhous = Rock hard (most stroma); Medullary = Soft (most parenchyma)
Signet ring = Mucin pushes nucleus aside
Pathological mitoses = Hallmark of cellular atypism = Malignancy
Tissue atypism ONLY = Benign; Tissue + Cellular atypism = Malignant
Locally destructive = Mature but infiltrating, no mets, CAN recur
Borderline = Cannot predict behaviour from morphology alone
Breast + Lung + Prostate = Early extensive metastases

This covers every slide, every term, every concept in your PPT, organized for the professor's conceptual/applied exam style. Each topic builds on the previous — study sequentially from Unit 1 → Unit 4, then drill the comparison tables and exam scenarios. Good luck — you have everything you need here.

This is a shared conversation. Sign in to Orris to start your own chat.